首页 / 院系成果 / 成果详情页

Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Final Results from an Open-Label, Randomized Phase 3 Study (GOYA) 会议论文 期刊论文

编号：

03059b05-8490-46fc-97c7-90c1804f6dcd
作者：

Vitolo, Umberto^[1] Trneny, Marek^[2] Belada, David^[3] Carella, Angelo M.^[4] Chua, Neil^[5] Abrisqueta, Pau^[6] Demeter, Judit^[7] Flinn, Ian W.^[8] Hong, Xiaonan^[9] Kim, Won Seog^[10] Pinto, Antonio^[11] Burke, John M.^[12,13] Shi, Yuankai^[14] Tatsumi, Yoichi^[15] Oestergaard, Mikkel^[16] Wenger, Michael K.^[17] FingerleRowson, Gunter^[16] Catalani, Olivier^[16] Nielsen, Tina^[16] Martelli, Maurizio^[18] Sehn, Laurie H.^[19]
语种：

English
期刊：

BLOOD ISSN：0006-4971 2016 年 128 卷 22 期 ; DEC 2
收录：
推荐引用方式
GB/T 7714：

Vitolo Umberto,Trneny Marek,Belada David, et al. Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Final Results from an Open-Label, Randomized Phase 3 Study (GOYA) [J].BLOOD,2016,128(22).
APA：

Vitolo Umberto,Trneny Marek,Belada David,Carella Angelo M.,&Sehn Laurie H..(2016).Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Final Results from an Open-Label, Randomized Phase 3 Study (GOYA) .BLOOD,128(22).
MLA：

Vitolo Umberto, et al. "Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Final Results from an Open-Label, Randomized Phase 3 Study (GOYA)" .BLOOD 128,22(2016).

浏览次数：9  下载次数：0

浏览次数：9

下载次数：0

打印次数：0

Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Final Results from an Open-Label, Randomized Phase 3 Study (GOYA) 会议论文期刊论文